These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19639168)

  • 41. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma.
    Piao GH; Piao WH; He Y; Zhang HH; Wang GQ; Piao Z
    Histol Histopathol; 2008 Oct; 23(10):1171-5. PubMed ID: 18712668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis.
    Kobayashi D; Nomoto S; Kodera Y; Fujiwara M; Koike M; Nakayama G; Ohashi N; Nakao A
    World J Surg; 2012 Feb; 36(2):362-72. PubMed ID: 22127425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway.
    Fu J; Lv H; Guan H; Ma X; Ji M; He N; Shi B; Hou P
    BMC Cancer; 2013 Oct; 13():462. PubMed ID: 24098937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
    Ko E; Seo HW; Jung ES; Kim BH; Jung G
    Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
    Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
    Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of MT1E as a novel tumor suppressor in hepatocellular carcinoma.
    Liu Q; Lu F; Chen Z
    Pathol Res Pract; 2020 Nov; 216(11):153213. PubMed ID: 32956919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
    Yang B; Guo M; Herman JG; Clark DP
    Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population.
    Maryam M; Idrees M
    J Med Virol; 2018 Sep; 90(9):1516-1523. PubMed ID: 29742286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma.
    Yu D; Zhang G; Huang X; Wu C; Tan W; Qiao Y; Chang J; Zhao H; Bi X; Cai J; Li Y; Lin D
    PLoS One; 2015; 10(5):e0126836. PubMed ID: 25965583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma.
    Chan KY; Lai PB; Squire JA; Beheshti B; Wong NL; Sy SM; Wong N
    Mod Pathol; 2006 Dec; 19(12):1546-54. PubMed ID: 16980951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
    Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.